| 000 | 01696 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250514205612.0 | ||
| 264 | 0 | _c20061020 | |
| 008 | 200610s 0 0 chi d | ||
| 022 | _a1007-3418 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLu, Lun-gen | |
| 245 | 0 | 0 |
_a[Oxymatrine in the treatment of chronic hepatitis B for one year: a multicenter random double-blind placebo-controlled trial]. _h[electronic resource] |
| 260 |
_bZhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology _cOct 2004 |
||
| 300 |
_a597-600 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAlkaloids _xadverse effects |
| 650 | 0 | 4 |
_aAntiviral Agents _xadverse effects |
| 650 | 0 | 4 | _aDouble-Blind Method |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHepatitis B, Chronic _xdrug therapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aQuinolizines |
| 700 | 1 | _aZeng, Min-de | |
| 700 | 1 | _aMao, Yi-min | |
| 700 | 1 | _aWan, Mo-bin | |
| 700 | 1 | _aLi, Cheng-zhong | |
| 700 | 1 | _aChen, Cheng-wei | |
| 700 | 1 | _aFu, Qing-chun | |
| 700 | 1 | _aWang, Ji-yao | |
| 700 | 1 | _aShe, Wei-min | |
| 700 | 1 | _aCai, Xiong | |
| 700 | 1 | _aYe, Jun | |
| 700 | 1 | _aZhou, Xia-qui | |
| 700 | 1 | _aWang, Hiu | |
| 700 | 1 | _aWu, Shan-ming | |
| 700 | 1 | _aTang, Mei-fang | |
| 700 | 1 | _aZhu, Jin-shui | |
| 700 | 1 | _aChen, Wei-xiong | |
| 773 | 0 |
_tZhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology _gvol. 12 _gno. 10 _gp. 597-600 |
|
| 999 |
_c15193359 _d15193359 |
||